NCT05636215
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05636215
Title A First-in-human Study of IBI354 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Scientia Clinical Research Ltd COMPLETED Randwick New South Wales 2031 Australia Details
Westmead Hospital COMPLETED Sydney New South Wales 2145 Australia Details
Sunshine Coast University Private Hospital COMPLETED Sunshine Coast Queensland 4575 Australia Details
Monash Health COMPLETED Clayton Victoria 3168 Australia Details
Peking University Cancer Hospital RECRUITING Beijing Beijing Municipality 100142 China Details
Affiliated Cancer Hospital of Chongqing University RECRUITING Chongqing Chongqing Municipality 400030 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field